{"database": "lobbying", "table": "lobbying_activities", "rows": [[2183963, "4140b7bb-5c51-4ebe-bdd1-88af6743bc1d", "Q3", "COVINGTON & BURLING LLP", 11195, "FLEXION THERAPEUTICS, INC.", 2018, "third_quarter", "PHA", "Education and support for public policies that promote the development, use, coverage and reimbursement of novel, non-opioid pain therapies, including FDA Opioid Sparing legislation.", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2018-10-15T10:23:11.977000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2183963"], "units": {}, "query_ms": 0.5725120427086949, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}